| Market Capitalization (Millions $) |
36 |
| Shares
Outstanding (Millions) |
14 |
| Employees |
91 |
| Revenues (TTM) (Millions $) |
37 |
| Net Income (TTM) (Millions $) |
-11 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that is headquartered in Nashville, Tennessee. The company specializes in the development, marketing, and distribution of branded prescription products for the treatment of acute care, gastroenterology, oncology, pain management, and ophthalmology.
Cumberland Pharmaceuticals was founded in 1999 by A.J. Kazimi, who currently serves as the Chief Executive Officer of the company. Since its inception, the company has developed and launched multiple products in the market, including its flagship product, Acetadote, which is primarily used as an antidote to acetaminophen toxicity.
The company's product portfolio includes Caldolor, a non-steroidal anti-inflammatory drug used for pain management, Kristalose, a prescription laxative used for the treatment of constipation, Hepatoren, a prescription product used for the management of hepatic encephalopathy, and Ethyol, a product used to reduce certain side effects associated with chemotherapy and radiation.
Cumberland Pharmaceuticals has a robust research and development program that involves both internal research efforts and collaborations with other pharmaceutical companies and academic institutions. The company has also established distribution partnerships with some of the leading pharmaceutical companies in the world, including Merck, Sanofi, and Lupin.
The company operates in the United States and several international markets, including Europe, the Middle East, and Asia. In addition to its pharmaceutical business, Cumberland also has a medical products division that develops and markets medical accessories and devices used in the healthcare industry.
According to its latest financial reports, Cumberland Pharmaceuticals recorded sales of $99 million in 2020, up from $98 million in the previous year, and had a workforce of approximately 180 employees. The company has received several awards and recognitions for its innovation and contribution to the pharmaceutical industry, including being named one of the fastest-growing companies in the United States by Inc. Magazine.
Company Address: 1600 West End Avenue Nashville 37203 TN
Company Phone Number: 255-0068 Stock Exchange / Ticker: NASDAQ CPIX
|
39.98 %